Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (401-410 of 692) with videos related to

Pageof 70
Sort By:
Cell Reports|May 7, 2020
Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized MedicineKrijn K Dijkstra, Kim Monkhorst, Luuk J Schipper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975Egbert F Smit, Jan P A M van Meerbeeck, Pilar Lianes, et al.
ERJ Open Research|December 21, 2019
Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysisDeirdre M H J Ten Berge, Daniel P Hurkmans, Ilse den Besten, et al.
Clinical Pharmacology and Therapeutics|July 21, 2020
Exposure-Response Analyses of Anaplastic Lymphoma Kinase Inhibitors Crizotinib and Alectinib in Non-Small Cell Lung Cancer PatientsStefanie L Groenland, Dieuwertje R Geel, Julie M Janssen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2023
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upL E Hendriks, K M Kerr, J Menis, et al.
Breast (Edinburgh, Scotland)|December 3, 2014
Feasibility of tailored follow-up for patients with early breast cancerMarjan van Hezewijk, Dennis J F Smit, Esther Bastiaannet, et al.
International Journal of Cancer|April 22, 1992
In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical dataE F Smit, E G de Vries, H Timmer-Bosscha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2023
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upL E Hendriks, K M Kerr, J Menis, et al.
British Journal of Cancer|November 23, 2016
Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatmentJ L Kuiper, S M S Hashemi, E Thunnissen, et al.
Eupa Open Proteomics|June 15, 2018
Peptide-mediated 'miniprep' isolation of extracellular vesicles is suitable for high-throughput proteomicsJaco C Knol, Inge de Reus, Tim Schelfhorst, et al.
Pageof 70

Showing results (401-410 of 692) with videos related to

Sort By:
Pageof 70
Cell Reports|May 7, 2020
Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized MedicineKrijn K Dijkstra, Kim Monkhorst, Luuk J Schipper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975Egbert F Smit, Jan P A M van Meerbeeck, Pilar Lianes, et al.
ERJ Open Research|December 21, 2019
Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysisDeirdre M H J Ten Berge, Daniel P Hurkmans, Ilse den Besten, et al.
Clinical Pharmacology and Therapeutics|July 21, 2020
Exposure-Response Analyses of Anaplastic Lymphoma Kinase Inhibitors Crizotinib and Alectinib in Non-Small Cell Lung Cancer PatientsStefanie L Groenland, Dieuwertje R Geel, Julie M Janssen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2023
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upL E Hendriks, K M Kerr, J Menis, et al.
Breast (Edinburgh, Scotland)|December 3, 2014
Feasibility of tailored follow-up for patients with early breast cancerMarjan van Hezewijk, Dennis J F Smit, Esther Bastiaannet, et al.
International Journal of Cancer|April 22, 1992
In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical dataE F Smit, E G de Vries, H Timmer-Bosscha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2023
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upL E Hendriks, K M Kerr, J Menis, et al.
British Journal of Cancer|November 23, 2016
Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatmentJ L Kuiper, S M S Hashemi, E Thunnissen, et al.
Eupa Open Proteomics|June 15, 2018
Peptide-mediated 'miniprep' isolation of extracellular vesicles is suitable for high-throughput proteomicsJaco C Knol, Inge de Reus, Tim Schelfhorst, et al.
Pageof 70